Chemours Co Stock Fundamentals
| CC Stock | USD 21.82 0.10 0.46% |
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
At present, Chemours' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 330.5 M, whereas Interest Expense is forecasted to decline to about 146.3 M. Chemours | Select Account or Indicator |
Chemours Co Company Operating Margin Analysis
Chemours' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Chemours Operating Margin | 0.1 % |
Most of Chemours' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Chemours Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Chemours Co has an Operating Margin of 0.0986%. This is 106.75% lower than that of the Chemicals sector and 101.72% lower than that of the Materials industry. The operating margin for all United States stocks is 101.79% lower than that of the firm.
Chemours Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemours competition to find correlations between indicators driving Chemours's intrinsic value. More Info.Chemours Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.36 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chemours Co is roughly 2.78 . At present, Chemours' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemours' earnings, one of the primary drivers of an investment's value.Chemours Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in operating margin category among its peers.
Chemours Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemours from analyzing Chemours' financial statements. These drivers represent accounts that assess Chemours' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemours' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0B | 3.0B | 4.1B | 4.8B | 4.7B | 3.6B | |
| Enterprise Value | 7.8B | 6.4B | 7.3B | 7.5B | 7.8B | 5.3B |
Chemours ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Chemours' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Chemours' managers, analysts, and investors.Environmental | Governance | Social |
Chemours Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0397 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 6.97 B | |||
| Shares Outstanding | 149.41 M | |||
| Shares Owned By Insiders | 0.72 % | |||
| Shares Owned By Institutions | 82.90 % | |||
| Number Of Shares Shorted | 7.28 M | |||
| Price To Earning | 25.49 X | |||
| Price To Book | 4.98 X | |||
| Price To Sales | 0.57 X | |||
| Revenue | 6.03 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 197 M | |||
| Net Income | (238 M) | |||
| Cash And Equivalents | 1.1 B | |||
| Cash Per Share | 7.73 X | |||
| Total Debt | 4.3 B | |||
| Debt To Equity | 2.94 % | |||
| Current Ratio | 1.82 X | |||
| Book Value Per Share | 4.40 X | |||
| Cash Flow From Operations | 556 M | |||
| Short Ratio | 4.18 X | |||
| Earnings Per Share | 0.50 X | |||
| Price To Earnings To Growth | 1.67 X | |||
| Target Price | 24.9 | |||
| Number Of Employees | 6.2 K | |||
| Beta | 1.75 | |||
| Market Capitalization | 3.28 B | |||
| Total Asset | 8.25 B | |||
| Retained Earnings | 1.78 B | |||
| Working Capital | 1.35 B | |||
| Current Asset | 2.3 B | |||
| Current Liabilities | 1.47 B | |||
| Annual Yield | 0.05 % | |||
| Five Year Return | 3.59 % | |||
| Net Asset | 8.25 B | |||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 370 M | 388.5 M | |
| Total Revenue | 6 B | 5.1 B | |
| Cost Of Revenue | 4.7 B | 3.8 B | |
| Sales General And Administrative To Revenue | 0.09 | 0.09 | |
| Research And Ddevelopement To Revenue | 0.02 | 0.02 | |
| Capex To Revenue | 0.06 | 0.07 | |
| Revenue Per Share | 40.47 | 40.34 | |
| Ebit Per Revenue | (0.02) | (0.01) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.